285 related articles for article (PubMed ID: 28719629)
21. Comparison between
Liu Y; Dong Y; Liu J; Zhang X; Lin M; Xu B
Prostate; 2021 Dec; 81(16):1329-1336. PubMed ID: 34516670
[TBL] [Abstract][Full Text] [Related]
22. Radiological Wheeler staging system: a retrospective cohort analysis to improve the local staging of prostate cancer with multiparametric MRI.
Russo F; Manfredi M; Panebianco V; Armando E; De Luca S; Mazzetti S; Giannini V; Mele F; Bollito E; Appendino E; Regge D; Porpiglia F
Minerva Urol Nefrol; 2019 Jun; 71(3):264-272. PubMed ID: 30654601
[TBL] [Abstract][Full Text] [Related]
23.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
24. Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Heck MM; Souvatzoglou M; Retz M; Nawroth R; Kübler H; Maurer T; Thalgott M; Gramer BM; Weirich G; Rondak IC; Rummeny EJ; Schwaiger M; Gschwend JE; Krause B; Eiber M
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):694-701. PubMed ID: 24297503
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic accuracy of
Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
[TBL] [Abstract][Full Text] [Related]
27. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
[TBL] [Abstract][Full Text] [Related]
28. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.
Abrams-Pompe RS; Fanti S; Schoots IG; Moore CM; Turkbey B; Vickers AJ; Walz J; Steuber T; Eastham JA
Eur Urol Oncol; 2021 Jun; 4(3):370-395. PubMed ID: 33272865
[TBL] [Abstract][Full Text] [Related]
29. Effect of Combined
Taneja S; Jena A; Taneja R; Singh A; Ahuja A
AJR Am J Roentgenol; 2018 Jun; 210(6):1338-1345. PubMed ID: 29528713
[TBL] [Abstract][Full Text] [Related]
30. 11C-acetate positron-emission tomography/computed tomography imaging for detection of recurrent disease after radical prostatectomy or radiotherapy in patients with prostate cancer.
Esch LH; Fahlbusch M; Albers P; Hautzel H; Müller-Mattheis V
BJU Int; 2017 Sep; 120(3):337-342. PubMed ID: 27860163
[TBL] [Abstract][Full Text] [Related]
31. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer.
Eschmann SM; Pfannenberg AC; Rieger A; Aschoff P; Müller M; Paulsen F; Anastasiadis A; Claussen CD; Bares R; Schlemmer HP
Nuklearmedizin; 2007; 46(5):161-8; quiz N47-8. PubMed ID: 17938748
[TBL] [Abstract][Full Text] [Related]
33. Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature.
Mohsen B; Giorgio T; Rasoul ZS; Werner L; Ali GR; Reza DK; Ramin S
BJU Int; 2013 Dec; 112(8):1062-72. PubMed ID: 23937453
[TBL] [Abstract][Full Text] [Related]
34. [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Hautzel H; Müller-Mattheis V; Herzog H; Roden W; Coenen HH; Ackermann R; Müller-Gärtner HW; Krause BJ
Urologe A; 2002 Nov; 41(6):569-76. PubMed ID: 12524944
[TBL] [Abstract][Full Text] [Related]
35.
Salminen A; Jambor I; Merisaari H; Ettala O; Virtanen J; Koskinen I; Veskimae E; Sairanen J; Taimen P; Kemppainen J; Minn H; Boström PJ
Cancer Imaging; 2018 Aug; 18(1):25. PubMed ID: 30068379
[TBL] [Abstract][Full Text] [Related]
36. Does 11C-choline PET-CT contribute to multiparametric MRI for prostate cancer localisation?
Van den Bergh L; Isebaert S; Koole M; Oyen R; Joniau S; Lerut E; Deroose CM; De Keyzer F; Van Poppel H; Haustermans K
Strahlenther Onkol; 2013 Sep; 189(9):789-95. PubMed ID: 23797481
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Accuracy of Multiparametric MRI versus
Muehlematter UJ; Burger IA; Becker AS; Schawkat K; Hötker AM; Reiner CS; Müller J; Rupp NJ; Rüschoff JH; Eberli D; Donati OF
Radiology; 2019 Nov; 293(2):350-358. PubMed ID: 31502937
[TBL] [Abstract][Full Text] [Related]
39. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Vees H; Buchegger F; Albrecht S; Khan H; Husarik D; Zaidi H; Soloviev D; Hany TF; Miralbell R
BJU Int; 2007 Jun; 99(6):1415-20. PubMed ID: 17428249
[TBL] [Abstract][Full Text] [Related]
40. A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer.
De Visschere PJL; Standaert C; Fütterer JJ; Villeirs GM; Panebianco V; Walz J; Maurer T; Hadaschik BA; Lecouvet FE; Giannarini G; Fanti S
Eur Urol Oncol; 2019 Feb; 2(1):47-76. PubMed ID: 30929846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
